Literature DB >> 9754142

Disaggregating pain and its effect on physical functional limitations.

M J Lichtenstein1, R Dhanda, J E Cornell, A Escalante, H P Hazuda.   

Abstract

BACKGROUND: Pain is a common impairment that limits the abilities of older persons. The purposes of this article are to: (i) describe the distribution of pain location using the McGill Pain Map (MPM) in a community-based cohort of aged subjects; (ii) investigate whether individual areas of pain could be sensibly grouped into regions of pain; (iii) determine whether intensity, frequency, and location constitute independent dimensions of pain; and (iv) determine whether these three pain dimensions make differential contributions to the presence of self-reported physical functional limitations.
METHODS: A total of 833 Mexican American and European American subjects, aged 65-79 years, were enrolled in the San Antonio Longitudinal Study of Aging and were interviewed in their homes between 1992 and 1996. A total of 373 (46%) of the subjects reported having pain in the past week. Physical functional limitations were ascertained using the nine items from the Nagi scale. Three composite scales were created: upper extremity, lower extremity, and total. Pain intensity and frequency were ascertained using the McGill Pain Questionnaire. Pain location was ascertained by using the MPM.
RESULTS: Pain was reported in every area of the MPM. Using multiple groups confirmatory factor analysis, the 36 areas were grouped into 7 regions of pain: head, arms, hands and wrists, trunk, back, upper leg, and lower leg. Among persons with pain, pain frequency, intensity, and location were weakly associated with each other. Pain regions were primarily independent of each other, yet weak associations existed between 6 of the 21 pair-wise correlations between regions. Pain regions were differentially associated with individual physical functional limitations. Pain in the upper leg was associated with 8 of the 9 physical tasks. In multivariate analyses, age, gender, and ethnic group accounted for only 2-3% of the variance in physical tasks. In multivariate analyses, age, gender, and ethnic group accounted for only 2-3% of the variance in physical functional limitations. Pain intensity accounted for 5-6% of the variance in the composite scores of functional limitation. Pain frequency accounted for 4-5% of the variance in upper extremity limitations but did not contribute to the modeling of lower extremity limitations. In contrast, pain location accounted for 9-14% of the variance in physical functional limitations.
CONCLUSIONS: We tested a method for ascertaining pain location and clearly demonstrated that pain location is an important determinant of self-reported physical functional limitations. The MPM methodology may be used in population-based studies or in clinical samples that focus on specific impairments and seek to control for pain frequency and intensity. Future studies can link specific diseases with the common impairment of pain and tease out the pathways that lead to other impairments (e.g., weakness), functional limitations, and disability.

Entities:  

Mesh:

Year:  1998        PMID: 9754142     DOI: 10.1093/gerona/53a.5.m361

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  17 in total

1.  Pain assessment in persons with dementia: relationship between self-report and behavioral observation.

Authors:  Ann L Horgas; Amanda F Elliott; Michael Marsiske
Journal:  J Am Geriatr Soc       Date:  2008-11-18       Impact factor: 5.562

2.  The association between noncancer pain, cognitive impairment, and functional disability: an analysis of the Canadian study of health and aging.

Authors:  Joseph W Shega; Debra K Weiner; Judith A Paice; S Pinar Bilir; Kenneth Rockwood; Keela Herr; Mary Ersek; Linda Emanuel; William Dale
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-29       Impact factor: 6.053

Review 3.  Pain in nursing home residents: management strategies.

Authors:  D K Weiner; J T Hanlon
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Pain and Cognitive Function Among Older Adults Living in the Community.

Authors:  Guusje van der Leeuw; Laura H P Eggermont; Ling Shi; William P Milberg; Alden L Gross; Jeffrey M Hausdorff; Jonathan F Bean; Suzanne G Leveille
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-10-03       Impact factor: 6.053

5.  The pathway from musculoskeletal pain to mobility difficulty in older disabled women.

Authors:  Suzanne G Leveille; Jonathan Bean; Long Ngo; William McMullen; Jack M Guralnik
Journal:  Pain       Date:  2006-10-19       Impact factor: 6.961

6.  Factors that modify the association between knee pain and mobility limitation in older women: the Women's Health and Aging Study.

Authors:  S E Lamb; J M Guralnik; D M Buchner; L M Ferrucci; M C Hochberg; E M Simonsick; L P Fried
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

7.  History of opioid use as a risk factor for current use and mental health consequences among retired National Football League athletes: A 9-year follow-up investigation.

Authors:  Zachary L Mannes; Eugene M Dunne; Erin G Ferguson; Linda B Cottler; Nicole Ennis
Journal:  Drug Alcohol Depend       Date:  2020-08-28       Impact factor: 4.492

8.  The relationship between pain and functional disability in Black and White older adults.

Authors:  Ann L Horgas; Saunjoo L Yoon; Austin Lee Nichols; Michael Marsiske
Journal:  Res Nurs Health       Date:  2008-08       Impact factor: 2.228

9.  Physical limitations and depressive symptoms: exploring the nature of the association.

Authors:  Mathew D Gayman; R Jay Turner; Ming Cui
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2008-07       Impact factor: 4.077

10.  Comparing pain severity versus pain location in the MOBILIZE Boston study: chronic pain and lower extremity function.

Authors:  Laura H P Eggermont; Jonathan F Bean; Jack M Guralnik; Suzanne G Leveille
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-19       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.